Gilberto Lopes, MD, MBA, FAMS

Articles by Gilberto Lopes, MD, MBA, FAMS

32 Impact of Comorbid HIV Infection on Breast Cancer Time to Treatment and Chemotherapy Relative Dose Intensity

ByElizabeth Rubin,Philippos Costa,Michael H. Antoni,Judith Hurley, MD,Gilberto Lopes, MD, MBA, FAMS,Danial S O’Neil

April 18th 2022

Gilberto Lopes, MD, MBA, FAMS, on Stopping Immunotherapy in Patients With Lung Cancer

ByGilberto Lopes, MD, MBA, FAMS

February 21st 2020

Gilberto Lopes, MD, MBA, FAMS, discussed his presentation about when to stop immunotherapy treatments for patients with lung cancer.

Latest Updated Articles

32 Impact of Comorbid HIV Infection on Breast Cancer Time to Treatment and Chemotherapy Relative Dose Intensity
April 18th 2022
Gilberto Lopes, MD, MBA, FAMS, on Stopping Immunotherapy in Patients With Lung Cancer
February 21st 2020

Trending on CancerNetwork

Belzutifan Combo Improves Disease Control Vs Cabozantinib in Advanced RCC

Lymphoma's Revolution: Evens & Rhodes on CLL, CAR-T, and NJ Care

Making Nuanced Decisions on CAR-T and Bispecifics in Multiple Myeloma

Novel Cancer Vaccine Meets Primary, Secondary End Points in Resected Melanoma

Managing Diarrhea and Optimizing Dose Reductions With NALIRIFOX